期刊文献+

Dynamic protein-protein interaction subnetworks of lung cancer in cases with smoking history 被引量:2

Dynamic protein-protein interaction subnetworks of lung cancer in cases with smoking history
下载PDF
导出
摘要 Smoking is the primary cause of lung cancer and is linked to 85% of lung cancer cases.However,how lung cancer develops in patients with smoking history remains unclear.Systems approaches that combine human protein-protein interaction (PPI) networks and gene expression data are superior to traditional methods.We performed these systems to determine the role that smoking plays in lung cancer development and used the support vector machine (SVM) model to predict PPIs.By defining expression variance (EV),we found 520 dynamic proteins (EV>0.4) using data from the Human Protein Reference Database and Gene Expression Omnibus Database,and built 7 dynamic PPI subnetworks of lung cancer in patients with smoking history.We also determined the primary functions of each subnetwork:signal transduction,apoptosis,and cell migration and adhesion for subnetwork A;cell-sustained angiogenesis for subnetwork B;apoptosis for subnetwork C;and,finally,signal transduction and cell replication and proliferation for subnetworks D-G.The probability distribution of the degree of dynamic protein and static protein differed,clearly showing that the dynamic proteins were not the core proteins which widely connected with their neighbor proteins.There were high correlations among the dynamic proteins,suggesting that the dynamic proteins tend to form specific dynamic modules.We also found that the dynamic proteins were only correlated with the expression of selected proteins but not all neighbor proteins when cancer occurred. Smoking is the primary cause of lung cancer and is linked to 85% of lung cancer cases. However, how lung cancer develops in patients with smoking history remains unclear. Systems approaches that combine human protein-protein interaction (PPI) networks and gene expression data are superior to traditional methods. We performed these systems to determine the role that smoking plays in lung cancer development and used the support vector machine (SVM) model to predict PPIs. By defining expression variance (EV), we found 520 dynamic proteins (EV〉0.4) using data from the Human Protein Reference Database and Gene Expression Omnibus Database, and built 7 dynamic PPI subnetworks of lung cancer in patients with smoking history. We also determined the primary functions of each subnetwork: signal transduction, apoptosis, and cell migration and adhesion for subnetwork A; cell-sustained angiogenesis for subnetwork B; apoptosis for subnetwork C; and, finally, signal transduction and cell replication and proliferation for subnetworks D-G. The probability distribution of the degree of dynamic protein and static protein differed, clearly showing that the dynamic proteins were not the core proteins which widely connected with their neighbor proteins. There were high correlations among the dynamic proteins, suggesting that the dynamic proteins tend to form specific dynamic modules. We also found that the dynamic proteins were only correlated with the expression of selected proteins but not all neighbor proteins when cancer occurred.
出处 《Chinese Journal of Cancer》 SCIE CAS CSCD 2013年第2期84-90,共7页
基金 supported by grants from the National Natural Science Foundation of China (No. 91130009) Science and Technology Planning Project of Guangdong Province of China (No. 2003A3080503)
关键词 蛋白质相互作用 肺癌 子网 吸烟 病例 基因表达数据 人类蛋白质 细胞凋亡 Lung cancer, protein-protein interaction (PPI), network
  • 相关文献

参考文献1

二级参考文献85

  • 1Sawyers C. Targeted cancer therapy. Nature,2004,432:294 -297.
  • 2Gerber DE. Targeted therapies: a new generation of cancertreatments. Am Fam Physician,2008,77:311-319.
  • 3Gottesman MM,Fojo T,Bates SE. Multidrug resistance incancer: role of ATP-dependent transporters. Nat Rev Cancer,2002,2:48-58.
  • 4Khan S,Elshaer A,Rahman AS,et al. Genomic evaluationduring permeability of indomethacin and its solid dispersion. JDrug Target,2011,19:615-623.
  • 5Okada H,Mak TW. Pathways of apoptotic and non-apoptoticdeath in tumour cells. Nat Rev Cancer,2004,4:592-603.
  • 6Brown JM,Attardi LD. The role of apoptosis in cancerdevelopment and treatment response. Nat Rev Cancer,2005,5:231-237.
  • 7Pao W,Miller VA,Politi KA,et al. Acquired resistance of lungadenocarcinomas to gefitinib or erlotinib is associated with asecond mutation in the EGFR kinase domain. PLoS Med,2005,2:e73.
  • 8Shtil AA,Azare J. Redundancy of biological regulation as thebasis of emergence of multidrug resistance. Int Rev Cytol,2005,246:1-29.
  • 9Kellner U,Sehested M,Jensen PB,et al. Culprit and victim—DNA topoisomerase II. Lancet Oncol,2002,3:235-243.
  • 10Lage H. An overview of cancer multidrug resistance: a stillunsolved problem. Cell Mol Life Sci,2008,65:3145-3167.

同被引文献3

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部